With 30% of COPD cases misdiagnosed, experts call for improved diagnostic strategies, better disease classification, and ...

Chronic obstructive pulmonary disease (COPD) is among the most common breathing conditions. It's the result of damaged lung ...

Most online pulmonary rehabilitation videos are understandable but lack key disease-specific information for conditions other than COPD.

People with chronic obstructive pulmonary disease (COPD) and arthritis have a higher risk of death than people with arthritis ...

Regeneron Pharmaceuticals, Inc. faces Eylea revenue decline but shows growth potential with Dupixent & Libtayo. Click for ...

For current and former smokers, statins may reduce the amount of chest muscle loss, while aspirin may contribute to increased ...

Young COPD, referring to cases of COPD that occur in people aged 20–50 years, is often overlooked in research and clinical ...

Mental health disorders in people with chronic obstructive pulmonary disease (COPD) are underdiagnosed and undertreated, ...

Early this year, Kamada announced that it expects continued double-digit growth – all while maintaining profitability – for ...

For current and former smokers, statins may reduce the amount of chest muscle loss, while aspirin may contribute to increased chest muscle loss, according to a new study.

Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.